If the market gets told over and over again by independent experts that PIQ products are working then we can be sure that eventually, those products will become a mainstream tool to predict future diseases.
And the share price will have to mirror this huge change in the medical practice of how to eveluate patients with those diseases.
Ann: PromarkerD clinical assay performance results published, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.025(6.41%) |
Mkt cap ! $59.74M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.0¢ | $70.59K | 189.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8100 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 13645 | 1 |
View Market Depth
| Last trade - 15.59pm 29/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |